Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023Business Wire • 02/06/23
Organon & Co. (OGN) CEO Kevin Ali Presents at 41st Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/10/23
Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive HysterectomyBusiness Wire • 01/05/23
Organon & Co. (OGN) Presents at Piper Sandler 34th Annual Healthcare ConferenceSeeking Alpha • 11/29/22
Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022Business Wire • 10/20/22
Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd)Business Wire • 08/17/22
Organon & Co. (OGN) CEO Kevin Ali on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/04/22
Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive CandidateBusiness Wire • 07/28/22
Organon To Report Second Quarter Results and Host Conference Call on August 4, 2022Business Wire • 07/21/22
Cognizant Teams Up with Organon to Speed Delivery of Pharmaceutical Products and Improve Women's HealthcarePRNewsWire • 07/21/22